Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 3, 2021, Cara Therapeutics, Inc. (the "Company") held its Annual Meeting
of Stockholders ("Annual Meeting"). At the Annual Meeting, the Company's
stockholders voted on the three proposals set forth below. A more detailed
description of each proposal is set forth in the Company's Proxy Statement filed
with the Securities and Exchange Commission on April 23, 2021.
Proposal 1 - Election of Directors
Mr. Harrison M. Bains, Jr. and Dr. Susan Shiff, Ph.D. were each elected to serve
as a director of the Company's Board of Directors until the 2024 Annual Meeting
of Stockholders and until his or her successor is duly elected or until his or
her earlier resignation or removal, by the following votes:
Nominee Votes For Votes Withheld Broker Non-Votes
Harrison M. Bains, Jr 28,448,858 836,904 11,995,880
Susan Shiff, Ph.D. 27,902,976 1,382,786 11,995,880
Proposal 2 - Approval, on a Non-Binding Advisory Basis, of the Compensation of
the Company's Named Executive Officers
The stockholders approved, on a non-binding advisory basis, the compensation of
the Company's named executive officers, by the following votes:
Votes For Votes Against Abstentions Broker Non-Votes
28,190,965 979,010 115,787 11,995,880
Proposal 3 - Ratification of the Selection of Independent Registered Public
Accounting Firm
The stockholders ratified the selection by the Audit Committee of the Board of
Directors of the Company of Ernst & Young LLP as the Company's independent
registered public accounting firm for the year ending December 31, 2021, by the
following votes:
Votes For Votes Against Votes Abstain Broker Non-Votes
39,581,075 1,661,532 39,035 -
© Edgar Online, source Glimpses